Woodside Energy Group Ltd
WDS
Origin Energy Ltd
ORG
Fortescue Ltd
FMG
Telstra Group Ltd
TLS
Rio Tinto Ltd
RIO
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.